Deep Track Capital, LP Tg Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 1,725,000 shares of TGTX stock, worth $59.1 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
1,725,000
Previous 2,870,131
39.9%
Holding current value
$59.1 Million
Previous $51.1 Million
20.98%
% of portfolio
1.49%
Previous 1.68%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
340Shares Held
88.5MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$527 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$390 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$312 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$123 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$110 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.98B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...